@article{buisson:hal-03870157, TITLE = {{Checking the absence of inflammatory activity with an objective marker, a key point to succeed the switch from intravenous to subcutaneous infliximab in inflammatory bowel disease}}, AUTHOR = {Buisson, Anthony and Nachury, Maria and Fumery, Mathurin}, URL = {https://u-picardie.hal.science/hal-03870157}, NOTE = {Letter}, JOURNAL = {{Clinical Gastroenterology and Hepatology}}, PUBLISHER = {{WB Saunders}}, YEAR = {2022}, MONTH = Nov, DOI = {10.1016/j.cgh.2022.11.006}, HAL_ID = {hal-03870157}, HAL_VERSION = {v1}, }